Sid Solaković, Mensur Vrcić, Ratko Pavlović


Inconspicuous epidemic of anabolic steroids application among young recreational athletes contributes to a greater potential damaging of the overall cardiovascular and mental state of obsessed individuals. All of them turn to anabolic steroids without a rational concept and take them in big amounts with unbelievable irrational combinations (stacking) of anabolic steroids of wide spectrum and questionable quality from black market with the aim to satisfy their pathological obsession of subjectivity of muscle mass, strength and appearance. An examinee, 36 years old (with the height of 182 cm and the weight of 168 kg), recreational amateur power lifter comes to doctor because of the subjective hardships in the form of tiredness and occasional pain in chest area with exact location (on the level of sternum and pectoral muscles), denies retrosternal pain. Also, he reports dizziness and occasional leg pain. He suspects that he has insufficiency of artery peripheral circulation. Personally, he also names frequent insomnia, decrease of tolerance levels alongside tolerated aggressiveness and anger attacks with auto mutilation and periodical depression


Article visualizations:

Hit counter



anabolic steroids, cardiovascular problem, social deviation

Full Text:



Petersson A., Benqtsson J., Voltaire-Carlsson A., & Thiblin I. (2010). Substance abusers’ motives for using anabolic androgenic steroids. Drug Alcohol Depend (111), 170–172.

Beaver K.M., Vaughn M.G., DeLisi M., & Wright J.P. (2008). Anabolic–androgenic steroid use and involvement in violent behavior in a nationally representative sample of young adult males in the United States. Am J Public Health (98), 2185–2186.

Midgley S.J., Heather N., & Davies J.B. (2001). Levels of aggression among a group of anabolic–androgenic steroid users. Med Sci Law (41), 309–314.

Lundholm L., Frisell T., Lichtenstein P., & Langstrom N. (2015). Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10 365 general population men. Addiction (110), 100–108.

Choi P.Y., & Pope H.G. Jr. (1994). Violence toward women and illicit androgenic-anabolic steroid use. Ann Clin Psychiatry (6), 21–25.

National Institute on Drug Abuse Research Report Series: Anabolic Steroid Abuse, 2006.

Schulze, Jenny J. & (2008). Doping Test Results Dependent on Genotype of UGT2B 17, the Major Enzyme for Testosterone Glucuronidation. Journal of Clinical Endocrinology & Metabolism March 11, 2018.

King D.S., Sharp R.L., & Vukovich M.D. (1999). Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. J Am Med Assn. (281), 2020-2028.

Wilson J.D. (1988). Androgen abuse by athletes. Endocr Rev. (9), 181-191.

Yeater R., Reed C., Ullrich I. & et al. (1996). Resistance trained athletes using or not using anabolic steroids compared to runners: effects on cardio respiratory variables, body composition, plasma lipids. Br J Sports Med. (30), 11-14.

Muller R.W., & Hollmann W. (1998). Akute Lipoproteibeeinflussung durchein anaboles Steroid bei Kraftsportlern. Dtsch Z Sportmed. (39), 35-40.

Zmuda J.M., Fahrenbach M.C., Younkin B.T., & et al. (1993). The effect of testosterone aromatization on high-density lipoprotein choles-terol level and postheparin lipolytic activity. Metabolism (42), 446-450.

Ale´n M., &Suominen J. (1984). Effect of androgenic and anabolic steroids on spermatogenesis in power athletes. Int J Sports Med. (5), 189-192.

Durstine J.L., & Haskell W.L. (1994). Effects of exercise training on plasma ma lipids and lipoproteins. In: Holloszy JO, editor. Exercise and sport sciences reviews. Baltimore (MD): Williams & Wilkins, 477-522.

Applebaum-Bowden D., Haffner S.M., & Hazzard WR. (1987). The dysli- poproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipo- protein2 cholesterol. Metabolism (36), 949-952.

Taggart H.M., Applebaum B.D., Haffner S., & et al. (1982). Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis. Metabolism (31), 1147-1152.

Turillazzi, E., Perilli, G., Di Paolo, M., Neri, M., Riezzo, I. & Fineschi, V. (2011). Side effects of AAS abuse: an overview. Mini Rev. Med. Chem. (11), 374-389.

Severo, C., Ribeiro, J., Umpierre, D., Silveira, A.D., Padilha,M., De Aquino Neto, F. & Stein, R. (2012) Increased atherothrombotic markers and endothelial dysfunction in steroid users. Eur. J. Prev. Cardiol. 20 (2), 195e201.

Fernandez-Balsells, M. Murad, M. Lane, J.F. Lampropulos, F. Albuquerque, R.J. Mullan, N. Agrwal, M. Elamin, J. Gallegos-Orozco, A. Wang, P. Erwin, S. Bhasin, V. Montori (2010). Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab.95 (6), 2560-2575.

Dawson, R. (2001). Drugs in sport-the role of the physician. J. Endocrinol. 170 (1), 55-61.

Ammatuna, E., Nijziel, M. (2014). Polycythemia and renal infarction in a bodybuilder. Q. J. Med. 107, 661.

Shahsavarinia, K., Rahmani, F., Ebrahimi Bakhtavar, F., Hashemi Aghdam,Y., Balafar, M. (2014). A young man with myocardial infection due to trenbolone acetate; acase report. Emergency 2 (1), 43-45.

Hartgens, F., Kuipers, H. & et al. (2004). Effects of androgenic-anabolic steroids in athletes.Sports Med.34(8),513-54.

Evans N.A. et al. (2006). Current concepts in anabolic-androgenic steroids. Am J Sports Med. 32(2), 534-542.

Kindermann W. (2006). Cardiovascular side effects of anabolic-androgenic steroids. Herz 31(6), 566-573.

Haug, E. et al., Androgenic-Anabolic Steroids (AAS) and Violent Behaviour. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 04-200.

Laye-Gindhu, A., Schonert-Reichl, Kimberly A. (2005)."Nonsuicidal Self-Harm Among Community Adolescents: Understanding the "Whats" and "Whys" of Self-Harm". Journal of Youth and Adolescence. 34 (5), 447–457.

Klonsky, D. (2007). The functions of deliberate self-injury: A review of the evidence. Clinical Psychological Review. 27 (2), 226–239.

Muehlenkamp, J.J. (2005). Self-Injurious Behavior as a Separate Clinical Syndrome. American Journal of Orthopsychiatry. 75 (2), 324–333.


  • There are currently no refbacks.

Copyright (c) 2019 Sid Solaković, Mensur Vrcić, Ratko Pavlović

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2015-2018. European Journal of Physical Education and Sport Science (ISSN 2501 - 1235) is a registered trademark of Open Access Publishing Group. All rights reserved.

This journal is a serial publication uniquely identified by an International Standard Serial Number (ISSN) serial number certificate issued by Romanian National Library (Biblioteca Nationala a Romaniei). All the research works are uniquely identified by a CrossRef DOI digital object identifier supplied by indexing and repository platforms. All authors who send their manuscripts to this journal and whose articles are published on this journal retain full copyright of their articles. All the research works published on this journal are meeting the Open Access Publishing requirements and can be freely accessed, shared, modified, distributed and used in educational, commercial and non-commercial purposes under a Creative Commons Attribution 4.0 International License (CC BY 4.0).